Related Experiment Video
Updated: Jan 10, 2026

Microtiter Dish Biofilm Formation Assay
Published on: January 30, 2011
Directed evolution of phages in biofilms enhances Pseudomonas aeruginosa control through improved lipopolysaccharide
Luciana Meneses1,2, Lucie Valentová3, Sílvio B Santos1,4
1CEB - Centre of Biological Engineering, University of Minho, Braga, Portugal.
Abstract:
Pseudomonas aeruginosa is a leading cause of chronic lung infections in cystic fibrosis (CF) patients. While bacteriophages hold potential as a treatment for antibiotic-resistant infections, the complex structure and heterogeneity of P. aeruginosa biofilms pose significant challenges to phage therapy. In this study, we investigate the adaptive evolution of the Pbunavirus phage PE1 to biofilms formed by a CF-derived P. aeruginosa isolate. Our findings reveal that biofilm-adapted PE1 mutants exhibit enhanced efficacy in controlling biofilms in vitro under conditions mimicking the CF lung environment. This improvement is attributed to the mutants' increased ability to recognize the diverse populations within the biofilm. Using a combination of cryo-EM, lipopolysaccharide (LPS) profiling, and adsorption assays, we demonstrate that mutations in tail fiber and baseplate genes of the phage improve adsorption and enable recognition of truncated LPS variants. This study highlights the critical role of biofilm heterogeneity in limiting phage effectiveness, identifies mechanisms to overcome this barrier, and pinpoints specific genomic targets for engineering phages tailored for therapeutic applications in CF patients.
Insights
Bacteriophages adapted to cystic fibrosis biofilms show improved efficacy against Pseudomonas aeruginosa. Mutations enhance phage recognition of diverse bacterial populations, paving the way for targeted phage therapy.
Area of Science:
- Microbiology
- Virology
- Biotechnology
Background:
- Pseudomonas aeruginosa is a major cause of chronic lung infections in cystic fibrosis (CF) patients.
- Bacteriophages are potential treatments for antibiotic-resistant infections, but P. aeruginosa biofilms present challenges.
- Biofilm heterogeneity limits phage effectiveness.
Purpose of the Study:
- To investigate the adaptive evolution of Pbunavirus phage PE1 to P. aeruginosa biofilms.
- To enhance phage efficacy in controlling CF-derived P. aeruginosa biofilms.
- To identify mechanisms for overcoming phage limitations in biofilm environments.
Main Methods:
- Studied adaptive evolution of phage PE1 to CF-derived P. aeruginosa biofilms.
- Utilized cryo-electron microscopy (cryo-EM), lipopolysaccharide (LPS) profiling, and adsorption assays.
- Analyzed mutations in phage tail fiber and baseplate genes.
Main Results:
- Biofilm-adapted PE1 mutants showed enhanced in vitro efficacy against P. aeruginosa biofilms.
- Mutants demonstrated improved recognition of diverse bacterial populations within biofilms.
- Mutations improved phage adsorption and enabled recognition of truncated LPS variants.
Conclusions:
- Biofilm heterogeneity is a key factor limiting phage therapy effectiveness.
- Specific phage mutations can overcome barriers to biofilm penetration and control.
- Genomic targets for engineering phages for CF patients were identified.
Related Concept Videos
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing
DNA Bacteriophages
Lytic Cycle of Bacteriophages

